cas 1297537-41-7|| where to buy (S)-4-(1-(2-Aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile

Product Name:(S)-4-(1-(2-Aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile

IUPAC Name:4-{1-[(2S)-2-aminopropyl]-1H-pyrazol-3-yl}-2-chlorobenzonitrile

Packing Unit	Available Stock	Price($)
CM493160-100mg	in stock	țȬ
CM493160-250mg	in stock	ũƎǶ
CM493160-1g	in stock	ǜƦǊ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1297537-41-7 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:1297537-41-7; Molecular Formula:C13H13ClN4; Melting Point:-; Smiles Code:N#CC1=CC=C(C2=NN(C[C@@H](N)C)C=C2)C=C1Cl; Density:

: Catalog Number:CM493160; Molecular Weight:260.73; Boiling Point:; MDL No:MFCD30802585; Storage:Keep in dark place,Inert atmosphere,2-8°C.

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Darolutamide; Bayer announced that its Phase 3 clinical ARANOTE trial met its primary endpoint. Its oral androgen receptor inhibitor (ARi) NUBEQA® (darolutamide) combined with androgen deprivation therapy (ADT) significantly improved radiographic progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). NUBEQA® (darolutamide) is an oral androgen receptor inhibitor with a distinct chemical structure that binds to androgen receptors with high affinity and exhibits strong antagonistic activity, thereby inhibiting receptor function and the growth of prostate cancer cells.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.